News and Announcements
Actinogen Receives Offer to Purchase All Less Than Marketable Parcels of Shares
- Published August 17, 2016 4:08PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
16th August 2016, ASX Announcement
The Board of Actinogen Medical Limited (ASX: ACW) (Actinogen or the Company) is pleased to announce that it has received an offer from an Australian financial services licensee to purchase all less than marketable parcels of shares in the Company for $0.0645 per share (Offer).
A less than “marketable parcel” (defined in the ASX Listing Rules as a parcel of shares with a market value of less than $500) will be any shareholding of 8,928 shares or less (Less than Marketable Parcel) on the record date. The record date for the purpose of establishing holders of Less Than Marketable Parcels has been set at close of trade on 15 August, 2016 (Record Date).
As at the Record Date, over 515 of the Company’s approximately 1,864 shareholders held Less Than Marketable Parcels, making up approximately 0.34% of the Company’s fully paid ordinary shares on issue.
To view the full announcement, please click on the button below.